Ogawa Katsuhiko

Prof. Dr. Ogawa Katsuhiko


Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2015 in Journal of Stroke and Cerebrovascular Diseases
Verified
Journal Article
Closed access
OKOgawa Katsuhiko
Ogawa Katsuhiko
YSYutaka Suzuki
Yutaka Suzuki
MOMinoru Oishi
Minoru Oishi
SKSatoshi Kamei
Satoshi Kamei

1 March 2017 in Journal of Stroke and Cerebrovascular Diseases
Verified
Journal Article
Closed access
OKOgawa Katsuhiko
Ogawa Katsuhiko
YSYutaka Suzuki
Yutaka Suzuki
KTKeiko Takahashi
Keiko Takahashi
TATakayoshi Akimoto
Takayoshi Akimoto
SKSatoshi Kamei
Satoshi Kamei
MSMasayoshi Soma
Masayoshi Soma

1 May 2013 in Journal of Stroke and Cerebrovascular Diseases
Verified
Journal Article
Closed access
OKOgawa Katsuhiko
Ogawa Katsuhiko
YSYutaka Suzuki
Yutaka Suzuki
MOMinoru Oishi
Minoru Oishi
SKSatoshi Kamei
Satoshi Kamei
SSShuntaro Shigihara
Shuntaro Shigihara
YNYasuyuki Nomura
Yasuyuki Nomura

1 October 2017 in Journal of Stroke and Cerebrovascular Diseases
Verified
Journal Article
Closed access
TATakayoshi Akimoto
Takayoshi Akimoto
OKOgawa Katsuhiko
Ogawa Katsuhiko
AMAkihiko Morita
Akihiko Morita
YSYutaka Suzuki
Yutaka Suzuki
SKSatoshi Kamei
Satoshi Kamei

1 July 2016 in Journal of Stroke and Cerebrovascular Diseases
Verified
Journal Article
Closed access
OKOgawa Katsuhiko
Ogawa Katsuhiko
YSYutaka Suzuki
Yutaka Suzuki
KTKeiko Takahashi
Keiko Takahashi
SKSatoshi Kamei
Satoshi Kamei
HIHiroshi Ishikawa
Hiroshi Ishikawa

9 January 2023 in Neurology International
Verified
Journal Article
Open access
PDF file
TATakayoshi Akimoto
Takayoshi Akimoto
MHMakoto Hara
Makoto Hara
MIMasaki Ishihara
Masaki Ishihara
OKOgawa Katsuhiko
Ogawa Katsuhiko
HNHideto Nakajima
Hideto Nakajima
Post-stroke pneumonia (PSP) has an impact on acute ischemic stroke (AIS). Although predictive scores for PSP have been developed, it is occasionally difficult to predict. Clarifying how PSP was treated after its onset in clinical practice is important. Admitted patients with AIS over a 2-year period were retrospectively reviewed. Of 281 patients with AIS, 24 (8.5%) developed PSP. The integer-based pneumonia risk score was higher in patients with PSP. The onset of PSP was frequently seen up to the 4th day of hospitalization. Of patients with PSP, sputum examination yielded Geckler 4 or 5 in only 8.3%. Angiotensin-converting enzyme inhibitor (ACE-I) was more frequently administered to patients with PSP; however, all these cases were started with ACE-I following PSP onset. Nasogastric tubes (NGTs) were inserted in 16 of the patients with PSP, of whom 11 were inserted following PSP onset. Multivariate analysis showed that PSP onset was a poor prognostic factor independent of the female sex, urinary tract infection, and National Institutes of Health Stroke Scale. PSP treatment would benefit from the administration of antimicrobials and ACE-I, as well as NGT insertion. To select effective agents for PSP and evaluate the indications for NGT insertion, further case studies are needed.